PT Sumber Sinergi Makmur Tbk (IDX:IOTF)
Indonesia · Delayed Price · Currency is IDR 83.00
+1.00 (1.22%)
At close: Aug 13, 2025, 3:30 PM WIB
Sage Therapeutics Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 64,087 | 62,955 | 70,533 | 51,013 | 31,530 | 17,174 | |
Revenue Growth (YoY) | -1.63% | -10.74% | 38.26% | 61.79% | 83.60% | - |
Cost of Revenue | 39,675 | 40,534 | 46,824 | 40,333 | 23,971 | 13,171 |
Gross Profit | 24,413 | 22,421 | 23,709 | 10,680 | 7,559 | 4,002 |
Selling, General & Admin | 17,328 | 16,606 | 13,138 | 6,860 | 3,864 | 2,245 |
Other Operating Expenses | 122.21 | 133.5 | 46.37 | 9.86 | - | - |
Operating Expenses | 21,185 | 19,241 | 15,555 | 7,437 | 4,108 | 2,354 |
Operating Income | 3,228 | 3,180 | 8,154 | 3,243 | 3,451 | 1,649 |
Interest Expense | -1,545 | -1,447 | -1,488 | -783.92 | -577.74 | -30.34 |
Interest & Investment Income | 9.06 | 7.14 | 3.51 | 2.06 | 2.26 | 0.61 |
Currency Exchange Gain (Loss) | -1.44 | 0.03 | 4.46 | -10.1 | 38.17 | - |
Other Non Operating Income (Expenses) | -144.13 | -191.25 | -1,322 | -455.14 | -44.02 | -42.85 |
EBT Excluding Unusual Items | 1,546 | 1,549 | 5,351 | 1,996 | 2,869 | 1,576 |
Asset Writedown | -0 | -0 | - | - | 11.22 | - |
Pretax Income | 1,546 | 1,549 | 5,351 | 1,996 | 2,881 | 1,576 |
Income Tax Expense | 1,223 | 1,223 | 1,212 | 525.93 | 639.34 | 313.27 |
Earnings From Continuing Operations | 323.7 | 326.19 | 4,139 | 1,470 | 2,241 | 1,263 |
Minority Interest in Earnings | 0.07 | -0.54 | -0.76 | - | - | - |
Net Income | 323.77 | 325.65 | 4,138 | 1,470 | 2,241 | 1,263 |
Preferred Dividends & Other Adjustments | 26.06 | 26.06 | 37.02 | - | - | - |
Net Income to Common | 297.71 | 299.59 | 4,101 | 1,470 | 2,241 | 1,263 |
Net Income Growth | -90.78% | -92.13% | 181.56% | -34.43% | 77.48% | - |
Shares Outstanding (Basic) | 5,286 | 5,282 | 4,077 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 5,286 | 5,282 | 4,077 | 20 | 20 | 20 |
Shares Change (YoY) | -0.74% | 29.58% | 20283.61% | - | - | - |
EPS (Basic) | 0.06 | 0.06 | 1.01 | 73.48 | 112.07 | 63.14 |
EPS (Diluted) | 0.06 | 0.06 | 1.01 | 73.48 | 112.07 | 63.14 |
EPS Growth | -91.37% | -94.36% | -98.63% | -34.43% | 77.48% | - |
Free Cash Flow | 11,952 | 1,901 | -139,792 | -25,622 | -5,795 | -2,349 |
Free Cash Flow Per Share | 2.26 | 0.36 | -34.29 | -1281.11 | -289.75 | -117.47 |
Gross Margin | 38.09% | 35.62% | 33.61% | 20.94% | 23.97% | 23.31% |
Operating Margin | 5.04% | 5.05% | 11.56% | 6.36% | 10.94% | 9.60% |
Profit Margin | 0.46% | 0.48% | 5.81% | 2.88% | 7.11% | 7.35% |
Free Cash Flow Margin | 18.65% | 3.02% | -198.19% | -50.23% | -18.38% | -13.68% |
EBITDA | 5,141 | 4,747 | 9,431 | 3,493 | 3,530 | 1,720 |
EBITDA Margin | 8.02% | 7.54% | 13.37% | 6.85% | 11.19% | 10.02% |
D&A For EBITDA | 1,914 | 1,567 | 1,277 | 250.41 | 78.84 | 71.26 |
EBIT | 3,228 | 3,180 | 8,154 | 3,243 | 3,451 | 1,649 |
EBIT Margin | 5.04% | 5.05% | 11.56% | 6.36% | 10.94% | 9.60% |
Effective Tax Rate | 79.07% | 78.94% | 22.66% | 26.36% | 22.19% | 19.88% |
Advertising Expenses | - | 3,197 | 2,870 | 766.81 | 672.83 | 20.32 |
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.